- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
CRM1 antibody recognizes Chromosome region maintenance 1, also known as Exportin 1 (XPO1), a key nuclear export receptor encoded by the XPO1 gene on chromosome 2p15. CRM1 is a central component of the karyopherin family that governs nucleocytoplasmic transport, ensuring proper trafficking of proteins and RNA species between the nucleus and cytoplasm. It recognizes leucine-rich nuclear export signals and binds cargo proteins together with Ran-GTP, forming export complexes that move through nuclear pore channels. CRM1 is essential for maintaining nuclear architecture, gene expression programs, and the spatial distribution of signaling molecules. It is expressed in a wide range of tissues and shows particularly high abundance in proliferative or metabolically active cell populations.
Chromosome region maintenance 1 participates in numerous pathways related to cell cycle progression, stress responses, immune signaling, and transcriptional regulation. CRM1 exports tumor suppressors, transcription factors, RNA-binding proteins, and regulators of apoptosis. Its cargo list includes proteins such as p53, FOXO transcription factors, STAT family members, NF-kB inhibitors, and components of ribosome biogenesis. By controlling the nuclear versus cytoplasmic distribution of these regulators, CRM1 influences cell growth, differentiation, and survival. It also plays roles in antiviral immunity by exporting viral RNA-protein complexes and participating in host defense mechanisms.
Dysregulation of CRM1 is implicated in several human diseases. Overexpression or hyperactivity of XPO1 is common in many cancers, including leukemia, lymphoma, breast cancer, ovarian cancer, and lung cancer. Elevated CRM1 levels can shift tumor suppressor proteins to the cytoplasm, diminishing their nuclear activity and contributing to oncogenesis. Pharmacologic inhibition of CRM1 has emerged as a therapeutic strategy, with several selective inhibitors undergoing clinical investigation to restore nuclear retention of critical regulatory proteins. Mutations in XPO1 have been identified in certain hematologic malignancies, further supporting its role in disease initiation and progression.
At the subcellular level, CRM1 localizes primarily to the nucleus and cytoplasm and concentrates around nuclear pore complexes where it co-localizes with importins, Ran regulators, and components of the nuclear transport machinery. Isoform variation may influence cargo specificity or regulatory interactions. CRM1 activity is tightly controlled by nucleotide binding states of Ran, post translational modifications, and interactions with nuclear pore-associated proteins. Developmentally, CRM1 expression increases during periods of rapid cell division and is essential for embryonic viability due to its role in regulating transcriptional and cell cycle networks.
This CRM1 antibody is suitable for detecting Chromosome region maintenance 1 in research focused on nuclear transport, cancer biology, stress signaling, transcriptional regulation, antiviral defense, and developmental pathways dependent on nucleocytoplasmic communication. It supports studies examining XPO1 function in tumorigenesis, nuclear export dysregulation, and gene expression control. NSJ Bioreagents provides this reagent within its nucleus and signaling-focused antibody catalog.
Optimal dilution of the CRM1 antibody should be determined by the researcher.
Amino acids N966-D1071 from the human protein were used as the immunogen for the CRM1 antibody.
After reconstitution, the CRM1 antibody can be stored for up to one month at 4oC. For long-term, aliquot and store at -20oC. Avoid repeated freezing and thawing.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.